Humedix Co., Ltd. (KOSDAQ:200670)

Market Cap	404.62B
Revenue (ttm)	110.99B
Net Income (ttm)	9.06B
Shares Out	10.31M
EPS (ttm)	963.99
PE Ratio	40.72
Forward PE	9.21
Dividend	550.00 (1.40%)
Ex-Dividend Date	Mar 28, 2025

Volume	223,271
Average Volume	130,688
Open	36,750
Previous Close	36,450
Day's Range	36,550 - 39,600
52-Week Range	25,400 - 46,450
Beta	0.56
RSI	59.36
Earnings Date	Feb 7, 2025

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2002
• Employees: 248
• Stock Exchange: KOSDAQ
• Ticker Symbol: 200670

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.